Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Screening and treating patients for obstructive sleep apnea before they have surgery may reduce their risk of cardiovascular complications by more than half.
The Food and Drug Administration (FDA) is warning parents and caregivers not to use "Bo Ying compound" manufactured by Eu Yan Sang (Hong Kong) Ltd. due a potential lead poisoning risk associated with the product.
The Food and Drug Administration (FDA) is warning about a slightly increased risk of cardiovascular and cerebrovascular events among patients being treated with Xolair (omalizumab; Genentech and Novartis) for asthma compared to those not treated with Xolair.
Boehringer Ingelheim announced that the Food and Drug Administration (FDA) has approved Spiriva Respimat (tiotropium bromide) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).
This program defines and distinguishes asthma from COPD, discusses the impact of these conditions on ...
Red flags - Respiratory tract infections